Literature DB >> 2978807

Echocardiographic and Doppler assessment of hypertrophic cardiomyopathy.

H Rakowski1, Z Sasson, E D Wigle.   

Abstract

Echocardiographic and Doppler studies are invaluable in the detection and management of patients with hypertrophic cardiomyopathy, since virtually all aspects of the disorder can be evaluated. Echocardiography is the primary method of diagnosis, and hemodynamic studies are required usually only when surgery is contemplated. All patients should if possible undergo complete M-mode, two-dimensional, Doppler, and color flow studies to define the extent of hypertrophy, the hemodynamic subgroup, quantitation of left ventricular outflow obstruction, mitral regurgitation when present, and an assessment of diastolic function. Patients undergoing medical or surgical therapy for this disorder should have repeat studies performed to assess the effects of therapy on the degree of obstruction and diastolic dysfunction.

Entities:  

Mesh:

Year:  1988        PMID: 2978807     DOI: 10.1016/s0894-7317(88)80062-2

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  8 in total

1.  Long-term survival after acute myocardial infarction in patients with hypertrophic cardiomyopathy.

Authors:  Yin-Jian Yang; Chao-Mei Fan; Jin-Qing Yuan; Hai-Bin Zhang; Fu-Jian Duan; Zhi-Min Wang; Xi-Ying Guo; Shan-Shan Zhai; Shuo-Yan An; Fei Hang; Yi-Shi Li
Journal:  Clin Cardiol       Date:  2016-10-17       Impact factor: 2.882

Review 2.  How has echo/Doppler influenced the practice of adult cardiology?

Authors:  R L Popp
Journal:  Int J Card Imaging       Date:  1993

3.  Mutations of the beta myosin heavy chain gene in hypertrophic cardiomyopathy: critical functional sites determine prognosis.

Authors:  A Woo; H Rakowski; J C Liew; M-S Zhao; C-C Liew; T G Parker; M Zeller; E D Wigle; M J Sole
Journal:  Heart       Date:  2003-10       Impact factor: 5.994

4.  Incidence of ischemic stroke and systemic embolism in patients with hypertrophic cardiomyopathy, nonvalvular atrial fibrillation, CHA2DS2-VASc score of ≤1 and without anticoagulant therapy.

Authors:  Yin-Jian Yang; Jin-Qing Yuan; Chao-Mei Fan; Jie-Lin Pu; Pi-Hua Fang; Jian Ma; Xi-Ying Guo; Yi-Shi Li
Journal:  Heart Vessels       Date:  2015-08-01       Impact factor: 2.037

5.  Long-term outcomes of childhood onset Noonan compared to sarcomere hypertrophic cardiomyopathy.

Authors:  Emanuel Kaltenecker; Julia Schleihauf; Christian Meierhofer; Nerejda Shehu; Naira Mkrtchyan; Alfred Hager; Andreas Kühn; Julie Cleuziou; Karin Klingel; Heide Seidel; Martin Zenker; Peter Ewert; Gabriele Hessling; Cordula M Wolf
Journal:  Cardiovasc Diagn Ther       Date:  2019-10

6.  A retrospective clinical study of transaortic extended septal myectomy for obstructive hypertrophic cardiomyopathy in China.

Authors:  Shuiyun Wang; Mingyao Luo; Hongtao Sun; Yunhu Song; Chaohua Yin; Liqing Wang; Rutai Hui; Shengshou Hu
Journal:  Eur J Cardiothorac Surg       Date:  2012-07-03       Impact factor: 4.191

7.  Subclinical Cardiac Dysfunction in Childhood Cancer Survivors on 10-Years Follow-Up Correlates With Cumulative Anthracycline Dose and Is Best Detected by Cardiopulmonary Exercise Testing, Circulating Serum Biomarker, Speckle Tracking Echocardiography, and Tissue Doppler Imaging.

Authors:  Cordula Maria Wolf; Barbara Reiner; Andreas Kühn; Alfred Hager; Jan Müller; Christian Meierhofer; Renate Oberhoffer; Peter Ewert; Irene Schmid; Jochen Weil
Journal:  Front Pediatr       Date:  2020-03-31       Impact factor: 3.418

Review 8.  Echocardiography in Athletes in Primary Prevention of Sudden Death.

Authors:  Juri Radmilovic; Antonello D'Andrea; Andrea D'Amato; Ercole Tagliamonte; Simona Sperlongano; Lucia Riegler; Raffaella Scarafile; Alberto Forni; Giuseppe Muscogiuri; Gianluca Pontone; Maurizio Galderisi; Maria Giovanna Russo
Journal:  J Cardiovasc Echogr       Date:  2019 Oct-Dec
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.